Trend of Novartis Cancer Trials
This week’s featured datacard is from our friend (and thoughtful beta user) Moe Alsumidaie from Annex Clinical. The datacard trends Novartis’ cancer (ICD-9 140-239) trials over time by trial start date. Trials have steadily increased over time and already have 10 started or planned for 2013. (As an aside, Moe runs a thoughtful on LinkedIn for those interested in the clinical space: Breakthrough Solutions in Clinical Trials and Healthcare.)
karmadata 
Very nice!
I have noticed you don’t monetize your page, don’t waste your traffic,
you can earn additional cash every month because you’ve got
high quality content. If you want to know how to
make extra bucks, search for: Boorfe’s tips best adsense alternative